We aimed to examine stage-specific oncologic outcomes for young versus conventional-age patients with localized disease in a modern cohort.
The Surveillance, Epidemiology and End Results database was queried for patients with T1-T2N0M0 kidney cancer from 1975-2016, including clear cell, papillary, and chromophobe renal cell carcinoma.